Materias dentro de su búsqueda.
Mostrando 24,461 - 24,480 Resultados de 24,879 Para Buscar '".eu"', tiempo de consulta: 0.27s Limitar resultados
  1. 24461
    “…METHODS: Data used in this paper came from a major EU program, called the Remote Assessment of Disease and Relapse–Major Depressive Disorder, which was conducted in 3 European countries. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Longitudinal Relationships Between Depressive Symptom Severity and Phone-Measured Mobility: Dynamic Structural Equation Modeling Study
  2. 24462
    “…CONCLUSIONS: Qualitative interviews show that dRTA and its treatment have a significant impact on QoL of patients and parents and that ADV7103 helps improve daily-life and reduces treatment burden, resulting in greater overall satisfaction of the patients and their families. Trial registration EU Clinical Trials Register, EudraCT 2013-003828-36 on the 3rd of September 2013.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Lived experiences of patients with distal renal tubular acidosis treated with ADV7103 and of their caregivers: a qualitative study
  3. 24463
    “…DISCUSSION: Based on the hypothesis that felzartamab is able to halt the progression of ABMR via targeting antibody-producing PC and NK cells, we believe that our trial could potentially provide the first proof of concept of a new treatment in ABMR based on a prospective randomized clinical trial. TRIAL REGISTRATION: EU Clinical Trials Register (EudraCT) 2021-000545-40. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Safety, tolerability, and efficacy of monoclonal CD38 antibody felzartamab in late antibody-mediated renal allograft rejection: study protocol for a phase 2 trial
  4. 24464
    “…PATIENTS ET MÉTHODES: Nous avons inclus 46 patients avec une plainte cognitive post-COVID-19 adressés au centre mémoire du CHU d’Amiens, ayant bénéficié d’une évaluation neuropsychologique, 36 d’entre eux ont eu une IRM cérébrale. Le score cognitif global G3 était la somme des scores z moyens qui prenait en compte les fonctions exécutives, le langage et la vitesse d’action. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Plainte cognitive post-COVID-19 : profil et déterminants
  5. 24465
    “…They were: trade agreements (divided into EU FTAs and those that include the USA); use of TRIPS flexibilities (divided into compulsory licencing and parallel importation); patent expiry/generic entry/generic pathway (divided into comparative studies and single country studies); patent policies (also divided into comparative studies and single country studies) and TRIPS-plus rules (divided into data exclusivity, patent term extensions and secondary patenting). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    What is the impact of intellectual property rules on access to medicines? A systematic review
  6. 24466
    “…The isolates were subdivided into 3 major phylogenetic groups. Type Mbovis-13 (Eu2 complex [western Europe and northern Africa]) included one isolate. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Mycobacterium bovis and M. caprae in Bulgaria: insight into transmission and phylogeography gained through whole-genome sequencing
  7. 24467
    “…-FNRS, Belgium), the « Fondation Roi Baudouin », the NEAT (European AIDS Treatment Network) program, the Internationale Brachet Stiftung, ViiV Healthcare, the Télévie, the Walloon Region (« Fonds de Maturation »), « Les Amis des Instituts Pasteur à Bruxelles, asbl », the University of Brussels (Action de Recherche Concertée ULB grant), the Marie Skodowska Curie COFUND action, the European Union's Horizon 2020 research and innovation program under grant agreement No 691119-EU4HIVCURE-H2020-MSCA-RISE-2015, the French Agency for Research on AIDS and Viral Hepatitis (ANRS), the Sidaction and the “Alsace contre le Cancer” Foundation. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Novel role of UHRF1 in the epigenetic repression of the latent HIV-1
  8. 24468
    “…On y trouvait 60 % (3) de femmes, 40 % (2) d’atopiques, un âge moyen : 50 ± 18 ans. Tous avaient eu une réaction immédiate (< 1 h), anaphylactique (choc anaphylactique dans 40 %, 2 cas)…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Modèle de stratification du risque allergique à la vaccination SARS-COV2 via un questionnaire (et bénéfice du bilan allergologique)
  9. 24469
    “…Il faut noter que les réactions urticariennes étaient toutes retardées de plus d’1 h ce qui est peu évocateur d’anaphylaxie IgE médiée. 217/225 patients ont eu une 2ème dose (dont 75 dans le service) parmi lesquels 2 ont présenté une réaction non grave non évocatrice d’allergie. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Retour d’expérience sur la vaccination anti-Covid-19 des patients étiquetés « à risque allergique »
  10. 24470
    “…EVIDENCE REVIEW: Medline, EMBASE, Cochrane, Web of Science, ClinicalTrials.gov, EU Clinical Trials Register, and the International Clinical Trials Registry Platform were searched for phase 3 trials of systemic therapy for patients with mCRC by decade (1986-1996, 1997-2006, and 2007-2016), excluding early or pilot studies, studies that did not involve an anticancer drug, studies on cancer screening and prevention, reports of pooled data from multiple trials, and studies with nonpharmaceutical approaches. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Overall Survival in Phase 3 Clinical Trials and the Surveillance, Epidemiology, and End Results Database in Patients With Metastatic Colorectal Cancer, 1986-2016: A Systematic Review
  11. 24471
    por Salmanton-García, Jon, Stewart, Fiona A., Heringer, Sarah, Koniordou, Markela, Álvarez-Barco, Elena, Argyropoulos, Christos D., Themistocleous, Sophia C., Valle-Simón, Paula, Spivak, Orly, Součková, Lenka, Merakou, Christina, Amélia Mendonça, Maria, Joanna Davis, Ruth, Maria Azzini, Anna, Askling, Helena H., Vene, Sirkka, Van Damme, Pierre, Steinbach, Angela, Shiamakkides, George, Seidel, Danila, Olesen, Ole F., Noula, Evgenia, Macken, Alan, Luís, Catarina, Leckler, Janina, Launay, Odile, Isitt, Catherine, Hellemans, Margot, Frías-Iniesta, Jesús, Di Marzo, Romina, Carcas, Antonio J., Boustras, George, Borobia, Alberto M., Barta, Imre, Albus, Kerstin, Akova, Murat, Ochando, Jordi, Cohen-Kandli, Miriam, Jane Cox, Rebecca, Husa, Petr, Jancoriene, Ligita, Mallon, Patrick, Marques, Laura, Mellinghoff, Sibylle C., Nauclér, Pontus, Tacconelli, Evelina, Tóth, Krisztina, Zaoutis, Theoklis E., Zeitlinger, Markus, Cornely, Oliver A., Pana, Zoi-Dorothea
    Publicado 2022
    “…METHODS: Interested volunteers who would like to register for clinical trials in the VACCELERATE Volunteer Registry can access the registration questionnaire via http://www.vaccelerate.eu/volunteer-registry. Potential volunteers are requested to provide their current country and area of residence, contact information, including first and last name and e-mail address, age, gender, comorbidities, previous SARS-CoV-2 infection and vaccination status, and maximum distance willing to travel to a clinical trial site. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    VACCELERATE Volunteer Registry: A European study participant database to facilitate clinical trial enrolment
  12. 24472
    “…Expert dermatologists (N = 14) participated from the USA (n = 8), EU (n = 4), India (n = 1), and Egypt (n = 1). All individuals with vitiligo reported experiencing skin depigmentation; an observable clinical sign of vitiligo. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Meaningful Changes in What Matters to Individuals with Vitiligo: Content Validity and Meaningful Change Thresholds of the Vitiligo Area Scoring Index (VASI)
  13. 24473
    “…Expert dermatologists from the US (n = 8), EU (n = 4), India (n = 1) and Egypt (n = 1) participated. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    A Qualitative Study to Develop and Evaluate the Content Validity of the Vitiligo Patient Priority Outcome (ViPPO) Measures
  14. 24474
    “…DISCUSSION/CONCLUSION: Notre étude nous a permis de déterminer la prévalence de la COVID longue dans un hôpital Tunisien et d’énumérer les symptômes résiduels les plus fréquents qui étaient : gêne respiratoire, troubles de la mémoire et asthénie. Ces symptômes ont eu un impact majeur sur la qualité de vie des patients. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Prévalence de la COVID longue - Données de l'unité COVID du service des urgences de l'hôpital de référence Abderrahmen Mami de l'Ariana
  15. 24475
    “…Both PC35 clusters contained multiple sequences with high homology (99%) to GenBank records DQ228358 and EU675312 that were both called “non-infectious IHHNV Type A” (IHHNV-A) when originally discovered. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Shrimp genome sequence contains independent clusters of ancient and current Endogenous Viral Elements (EVE) of the parvovirus IHHNV
  16. 24476
    “…If there is evidence for the superiority of BUP-XR over SOC medication, study findings will have substantial implications for OUD clinical practice and treatment policy in the UK and elsewhere. TRIAL REGISTRATION: EU Clinical Trials register 2018-004460-63. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13063-022-06595-0.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Extended-release pharmacotherapy for opioid use disorder (EXPO): protocol for an open-label randomised controlled trial of the effectiveness and cost-effectiveness of injectable buprenorphine versus sublingual tablet buprenorphine and oral liquid methadone
  17. 24477
    “…INTRODUCTION: Solriamfetol (Sunosi™), a dopamine/norepinephrine reuptake inhibitor, is approved (USA and EU) to treat excessive daytime sleepiness (EDS) in adults with obstructive sleep apnea (OSA) (37.5–150 mg/day). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Solriamfetol Titration and AdministRaTion (START) in Patients with Obstructive Sleep Apnea: A Retrospective Chart Review and Hypothetical Patient Scenario
  18. 24478
    “…CONCLUSION: En Algérie, la lutte contre la pandémie de COVID-19 a eu un impact sur la santé mentale des professionnels de santé. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Impact psychosocial de la COVID-19 chez le personnel de santé
  19. 24479
    “…INTRODUCTION: La pandémie COVID-19 a eu d’importantes répercussions sur la santé physique et psychologique des personnes ayant contracté le virus du SARS-CoV-2. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Qualité de vie chez le personnel hospitalier rétabli de COVID-19
  20. 24480
    “…Furthermore, we performed a technological readiness study of ProHealth eCoach against standard levels set by European Union (EU). SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12913-022-08441-0.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    ProHealth eCoach: user-centered design and development of an eCoach app to promote healthy lifestyle with personalized activity recommendations
Herramientas de búsqueda: RSS